Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials: Effect of measurement criteria and other parameters Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Renal Cell
  • Kidney Neoplasms

abstract

  • The use of unidimensional measurements in RCC therapy assessment results in significantly different time to progression classification compared with the use of bidimensional measurements. Response assessment classification in patients with RCC is affected by the exclusion or inclusion of measurements of the primary renal tumor. The normalized lesion index warrants further study in assessing response in patients with metastatic RCC and other solid tumor malignancies that often show substantial differences in sizes of measurable lesions.

publication date

  • October 15, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.11712

PubMed ID

  • 14534876

Additional Document Info

start page

  • 1611

end page

  • 9

volume

  • 98

number

  • 8